logo-loader

Friday preview: Computacenter interims may provide more detail on outlook

Insulation specialist Kingspan is also expected to report growth in its own first-half numbers

Computacenter - computer keyboard
Computacenter recently upgraded its profit guidance for the full year

On Friday, Computacenter PLC (LON:CCC) will report on first-half results, having revealed at the end of the first quarter that customers did not seem to be deterred by the “slightly more challenging economic conditions throughout our major markets”.

The FTSE-250 IT supplier also recently said that underlying adjusted profit before tax in the first half was “marginally ahead” of last year's £52mln and raised its outlook for the full year to a level “materially ahead of current market expectations”. 

This mainly reflected the fact that last year management took a number of provisions on mainly on German outsourcing contracts and it now feels the level of provisioning is adequate and so new provision creation will “reduce significantly” in the second half. 

UBS noted that Computacenter had taken £14mln of specific contract-related provisions in 2018, up from £4mln in 2017, “pointing to the potential magnitude of benefit”.

There are also interims scheduled for Kingspan Group plc (LON:KGP), the specialist in insulation, facades and ‘building envelopes’.

For this FTSE SmallCap outfit, UBS analysts expect first-half sales growth of 14% to €2.3bn, driven by 5% like-for-like growth, 8% from acquisitions and some currency benefit. 

Trading profit is pencilled at €325mln, representing growth of 20% as margin expansion is driven by deflation in commodity prices. 

The analysts concluded, “we think guidance could imply some upside to consensus EBITA estimates of ~€480m (UBSE €500m), with upside likely from input costs. The downside risk is the evolution of end markets, in particular the UK.”

Friday August 23:  

InterimsComputacenter PLC (LON:CCC), Glenveagh PLC (LON:GLV), Kingspan Group Plc (LON:KGP), Afarak Group PLC (AFRK)

Economic data: US new home sales

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: CB2 Insights licenses electronic data capture software to UK...

CB2 Insights (CSE:CBII-OTCQB: CBIIF) CEO Prad Sekar joined Steve Darling from Proactive Vancouver to discuss the company doing a deal with MYACCESS Clinics. This will allow CB2’s software to capture comprehensive data sets related to patient health and treatment histories and manage ongoing...

13 hours ago

2 min read